Get the latest tech news
Forget Psychedelics. Everyone's Microdosing Ozempic Now
Sure, who wouldn’t want to lose a few pounds? But what’s really driving Hollywood’s latest trend is the drug’s seemingly miraculous side benefits
Shamoon has joined the wave of people who are taking limited amounts not of psychedelics — to which the microdosing trend usually applies — but of the diabetes drug Ozempic(semaglutide), and other GLP-1 receptor agonists like Mounjaro. “Unlike traditional dosing, which primarily targets appetite suppression and glucose regulation, microdosing semaglutide may provide a more gradual, sustained effect on the brain, immune system and overall cellular health,” she notes. Even for those who merely want to lose a few pounds, microdosing has its advantages, because the regular FDA starting measure can produce unpleasant side effects like burping, nausea and indigestion, along with muscle atrophy and the dreaded saggy or drawn “Ozempic face” that comes from rapid weight loss.
Or read this on Hacker News
